PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, Washington University School of Medicine, St. Louis, St. Louis, MO, USA.\', \'Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, St. Louis, MO, USA.\', \'Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, St. Louis, MO, USA.\', \'The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, St. Louis, MO, USA.\', \'Department of Immunology, St. Jude Children\'s Research Hospital, Memphis, TN, USA. thirumala-devi.kanneganti@stjude.org.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41590-021-01091-0
?:hasPublicationType
?:journal
  • Nature immunology
is ?:pmid of
?:pmid
?:pmid
  • 35105981
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 14.007
?:rankingScore_hIndex
  • 336
?:title
  • Innate immunity: the first line of defense against SARS-CoV-2.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all